Understanding Neuroinflammaging and Brain Fog

Chronic inflammation often leads to cognitive decline in the elderly. However, a new nasal spray brain aging therapy may offer a solution. Researchers at Texas A&M University used microRNAs to reverse cognitive decline in mice. This study indicates that we might reverse the inflammatory tide responsible for brain fog. Low-grade inflammation often persists deep within the brain\'s memory center. Consequently, this \"neuroinflammaging\" creates a persistent brain fog. This fog makes it harder to think or form new memories. Furthermore, chronic inflammation increases the risk of Alzheimer\'s disease. Therefore, scientists are looking for ways to stop this slow burn without invasive surgery.

How the nasal spray brain aging Therapy Works

The researchers used microscopic delivery vehicles called extracellular vesicles. These vesicles carry microRNAs that act as master regulators. Because the spray is intranasal, it travels directly to the brain tissue. It successfully bypasses the brain\'s protective shield. Then, the microRNAs suppress specific systems that drive chronic inflammation. Specifically, they target the NLRP3 inflammasome and cGAS-STING signalling pathways. This non-invasive approach ensures the therapy reaches the hippocampus effectively. Thus, the treatment avoids the risks associated with brain surgery. In addition, the effects of just two doses lasted for several months in preclinical models.

Recharging Mitochondrial Power Plants

The treatment also recharges the \"power plants\" inside brain cells. These mitochondria often fail as we age. However, the therapy reduces oxidative stress and restores their function. In trials, mice showed significant improvements in recognizing familiar objects. They also detected changes in their environment more quickly. This suggests that the brain can indeed repair itself when given the right tools. Moreover, the researchers believe this could reshape the future of neurodegenerative therapies. Mentally sharp aging may soon become a reality through regenerative medicine. Consequently, this study provides hope for those facing age-related cognitive decline.

Frequently Asked Questions

Q1: How does the nasal spray reach the brain directly?

The spray uses extracellular vesicles to bypass the blood-brain barrier. These microscopic vehicles travel along the olfactory nerves to reach brain tissue without invasive procedures.

Q2: What role do microRNAs play in this brain therapy?

MicroRNAs act as master regulators that modulate gene and signalling pathways. They specifically suppress the inflammatory systems that cause chronic brain aging and memory loss.

Q3: Has this nasal spray therapy been tested in humans?

Currently, the research is in the preclinical stage using mouse models. However, the team has filed a patent and plans further research to transition toward human clinical trials.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Researchers use nasal spray to suppress brain inflammation, reverse ageing - ETHealthworld


2. Shetty AK, et al. Intranasal Human NSC-Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS-STING Signalling, in Aged Hippocampus. Journal of Extracellular Vesicles. 2026;15(2):e70232.


3. Texas A&M University. Scientists reverse brain aging, with a nasal spray. Texas A&M Stories. Published April 14, 2026.